Carta al Director
Dosis de protionamida y PAS. Corrección al «Documento de Consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis»
Corrigendum: Consensus Document on the Diagnosis, Treatment and Prevention of Tuberculosis. Prothionamide and PAS Doses
Read
7181
Timeswas read the article
1766
Total PDF
5415
Total HTML
Share statistics
array:23 [ "pii" => "S0300289615003099" "issn" => "03002896" "doi" => "10.1016/j.arbres.2015.07.004" "estado" => "S300" "fechaPublicacion" => "2015-10-01" "aid" => "1225" "copyright" => "SEPAR" "copyrightAnyo" => "2015" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2015;51:533" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2916 "formatos" => array:3 [ "EPUB" => 113 "HTML" => 2216 "PDF" => 587 ] ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S1579212915002906" "issn" => "15792129" "doi" => "10.1016/j.arbr.2015.08.005" "estado" => "S300" "fechaPublicacion" => "2015-10-01" "aid" => "1225" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2015;51:533" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1815 "formatos" => array:3 [ "EPUB" => 129 "HTML" => 1196 "PDF" => 490 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Corrigendum: Consensus Document on the Diagnosis, Treatment and Prevention of Tuberculosis. Prothionamide and PAS Doses" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "533" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Dosis de protionamida y PAS. Corrección al «Documento de Consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis»" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José-María García-García, Julià González-Martín" "autores" => array:2 [ 0 => array:2 [ "nombre" => "José-María" "apellidos" => "García-García" ] 1 => array:2 [ "nombre" => "Julià" "apellidos" => "González-Martín" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289615003099" "doi" => "10.1016/j.arbres.2015.07.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289615003099?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915002906?idApp=UINPBA00003Z" "url" => "/15792129/0000005100000010/v1_201509302252/S1579212915002906/v1_201509302252/en/main.assets" ] ] "itemAnterior" => array:19 [ "pii" => "S0300289615001556" "issn" => "03002896" "doi" => "10.1016/j.arbres.2015.04.010" "estado" => "S300" "fechaPublicacion" => "2015-10-01" "aid" => "1186" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2015;51:533" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2144 "formatos" => array:3 [ "EPUB" => 91 "HTML" => 1550 "PDF" => 503 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "La excepción no confirma la regla" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "533" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The Exception does not Prove the Rule" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Adolfo Baloira Villar, Marta Núñez Fernández" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Adolfo" "apellidos" => "Baloira Villar" ] 1 => array:2 [ "nombre" => "Marta" "apellidos" => "Núñez Fernández" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212915002761" "doi" => "10.1016/j.arbr.2015.07.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915002761?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289615001556?idApp=UINPBA00003Z" "url" => "/03002896/0000005100000010/v1_201509302001/S0300289615001556/v1_201509302001/es/main.assets" ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Dosis de protionamida y PAS. Corrección al «Documento de Consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis»" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">Sr. Director:</span>" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "533" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "José-María García-García, Julià González-Martín" "autores" => array:2 [ 0 => array:4 [ "nombre" => "José-María" "apellidos" => "García-García" "email" => array:1 [ 0 => "josemaria.garciag@sespa.es" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Julià" "apellidos" => "González-Martín" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Unidad de Gestión Clínica de Neumología. Hospital San Agustín, Avilés, España" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servei de Microbiologia, Hospital Clínic-ISGLOBAL, Universitat de Barcelona, Barcelona, España" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Coordinación del Consenso por parte de SEPAR y SEIMC respectivamente, en nombre de todos los autores" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Autor para correspondencia." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Corrigendum: Consensus Document on the Diagnosis, Treatment and Prevention of Tuberculosis. Prothionamide and PAS Doses" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">En relación con el «Documento de Consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis» realizado por la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) y por la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), publicado simultáneamente y con idéntico contenido en las órganos de expresión oficiales de ambas Sociedades, las revistas Archivos de Bronconeumología y Enfermedades Infecciosas y Microbiología Clínica<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">1,2</span></a>, los redactores de esta carta, como autores del Consenso quisiéramos hacer las siguientes consideraciones:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1.</span><p id="par0010" class="elsevierStylePara elsevierViewall">Se ha detectado un error en las dosis recomendada de PAS (ácido para-amino-salicílico) y de protionamida. Así en la Tabla 11 del Consenso se han intercambiado las dosis de ambos fármacos, constando para el PAS la dosis de protionamida y vicerversa, para la protionamida la dosis de PAS.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2.</span><p id="par0015" class="elsevierStylePara elsevierViewall">La dosis de PAS es de 8 a 12 gramos al día, repartidos en 2–3 dosis.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3.</span><p id="par0020" class="elsevierStylePara elsevierViewall">La dosis de protionamida es de 10-15<span class="elsevierStyleHsp" style=""></span>mg/kg/día (en dos dosis).</p></li></ul></p><p id="par0025" class="elsevierStylePara elsevierViewall">Los cambios se expresan en la <a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">Por último nos gustaría hacer una recomendación en relación con las dosis de los medicamentos utilizados en el tratamiento de la tuberculosis, y es que nos parecen útiles los documentos publicados por <span class="elsevierStyleItalic">TB Alliance</span><a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> y la Organización Mundial de la Salud<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">4</span></a> cuyos enlaces se detallan en la bibliografía.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Esperando nos faciliten la difusión de esta carta, les saluda atentamente.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Tabla 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:3 [ "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Corresponde a la Tabla 11 del «Documento de Consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis»<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">1,2</span></a>.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Categoría \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Fármaco \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Dosis en adultos \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Inyectables \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">AmikacinaCapreomicina<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>Kanamicina \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15 mg/kg/día15 mg/kg/día15 mg/kg/día \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Fluoroquinolonas \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Moxifloxacino<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> LevofloxacinoOfloxacino \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">400 mg/24h500 mg/12h400 mg/12h \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Otros \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">CicloserinaPASProtionamida<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15-20 mg/kg/día (en 2-3 dosis)8-12 gr/día (en 2-3 dosis)10-15 mg/kg/día (en 2 dosis) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab905851.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Fármacos de utilización preferente en cada grupo.</p>" ] ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Fármacos de segunda línea en el tratamiento de la tuberculosis</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0025" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Documento de consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. González-Martín" 1 => "J.M. García-García" 2 => "L. Anibarro" 3 => "R. Vidal" 4 => "J. Esteban" 5 => "S. Moreno" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2010.02.010" "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol." "fecha" => "2010" "volumen" => "46" "paginaInicial" => "255" "paginaFinal" => "274" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20444533" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0030" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Documento de consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. González-Martín" 1 => "J.M. García-García" 2 => "L. Anibarro" 3 => "R. Vidal" 4 => "J. Esteban" 5 => "S. Moreno" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.eimc.2010.02.006" "Revista" => array:5 [ "tituloSerie" => "Enferm Infecc Microbiol Clin." "fecha" => "2010" "volumen" => "28" "paginaInicial" => "297" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20435388" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0035" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Handbook of Anti-Tuberculosis Agents. Tuberculosis. 2008;88:85-170. [consultado 6 Jul 2015]. Disponible en <a href="http://www.tballiance.org/newscenter/research_papers/TB_DB_Final.pdf">http://www.tballiance.org/newscenter/research_papers/TB_DB_Final.pdf</a>" ] ] ] 3 => array:3 [ "identificador" => "bib0040" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. 2014. WHO/HTM/TB/2014.11. [consultado 6 Jul 2015]. Disponible en: <a href="http://apps.who.int/iris/bitstream/10665/130918/1/9789241548809_eng.pdf">http://apps.who.int/iris/bitstream/10665/130918/1/9789241548809_eng.pdf</a>" ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/03002896/0000005100000010/v1_201509302001/S0300289615003099/v1_201509302001/es/main.assets" "Apartado" => array:4 [ "identificador" => "9222" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Letters to the Director / Cartas al Director" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/03002896/0000005100000010/v1_201509302001/S0300289615003099/v1_201509302001/es/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289615003099?idApp=UINPBA00003Z" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 11 | 1 | 12 |
| 2024 October | 60 | 17 | 77 |
| 2024 September | 74 | 11 | 85 |
| 2024 August | 92 | 32 | 124 |
| 2024 July | 65 | 27 | 92 |
| 2024 June | 101 | 25 | 126 |
| 2024 May | 81 | 28 | 109 |
| 2024 April | 77 | 25 | 102 |
| 2024 March | 78 | 29 | 107 |
| 2024 February | 55 | 34 | 89 |
| 2023 March | 13 | 5 | 18 |
| 2023 February | 75 | 18 | 93 |
| 2023 January | 65 | 23 | 88 |
| 2022 December | 94 | 38 | 132 |
| 2022 November | 85 | 19 | 104 |
| 2022 October | 78 | 23 | 101 |
| 2022 September | 64 | 28 | 92 |
| 2022 August | 64 | 34 | 98 |
| 2022 July | 43 | 39 | 82 |
| 2022 June | 70 | 25 | 95 |
| 2022 May | 84 | 29 | 113 |
| 2022 April | 73 | 27 | 100 |
| 2022 March | 70 | 30 | 100 |
| 2022 February | 88 | 23 | 111 |
| 2022 January | 79 | 21 | 100 |
| 2021 December | 63 | 40 | 103 |
| 2021 November | 92 | 41 | 133 |
| 2021 October | 65 | 31 | 96 |
| 2021 September | 50 | 49 | 99 |
| 2021 August | 58 | 27 | 85 |
| 2021 July | 86 | 24 | 110 |
| 2021 June | 82 | 32 | 114 |
| 2021 May | 50 | 27 | 77 |
| 2021 April | 122 | 65 | 187 |
| 2021 March | 102 | 21 | 123 |
| 2021 February | 60 | 15 | 75 |
| 2021 January | 57 | 21 | 78 |
| 2020 December | 54 | 25 | 79 |
| 2020 November | 79 | 13 | 92 |
| 2020 October | 69 | 17 | 86 |
| 2020 September | 54 | 16 | 70 |
| 2020 August | 43 | 18 | 61 |
| 2020 July | 42 | 21 | 63 |
| 2020 June | 47 | 12 | 59 |
| 2020 May | 60 | 15 | 75 |
| 2020 April | 47 | 12 | 59 |
| 2020 March | 58 | 21 | 79 |
| 2020 February | 52 | 16 | 68 |
| 2020 January | 62 | 24 | 86 |
| 2019 December | 42 | 20 | 62 |
| 2019 November | 52 | 20 | 72 |
| 2019 October | 87 | 10 | 97 |
| 2019 September | 52 | 14 | 66 |
| 2019 August | 39 | 10 | 49 |
| 2019 July | 45 | 23 | 68 |
| 2019 June | 30 | 13 | 43 |
| 2019 May | 81 | 39 | 120 |
| 2019 April | 85 | 33 | 118 |
| 2019 March | 44 | 23 | 67 |
| 2019 February | 35 | 20 | 55 |
| 2019 January | 26 | 15 | 41 |
| 2018 December | 36 | 12 | 48 |
| 2018 November | 48 | 14 | 62 |
| 2018 October | 75 | 19 | 94 |
| 2018 September | 35 | 7 | 42 |
| 2018 July | 3 | 0 | 3 |
| 2018 May | 27 | 0 | 27 |
| 2018 April | 27 | 7 | 34 |
| 2018 March | 31 | 5 | 36 |
| 2018 February | 47 | 10 | 57 |
| 2018 January | 104 | 11 | 115 |
| 2017 December | 111 | 10 | 121 |
| 2017 November | 26 | 7 | 33 |
| 2017 October | 37 | 10 | 47 |
| 2017 September | 19 | 10 | 29 |
| 2017 August | 25 | 10 | 35 |
| 2017 July | 20 | 6 | 26 |
| 2017 June | 36 | 14 | 50 |
| 2017 May | 37 | 6 | 43 |
| 2017 April | 28 | 5 | 33 |
| 2017 March | 17 | 7 | 24 |
| 2017 February | 17 | 7 | 24 |
| 2017 January | 20 | 2 | 22 |
| 2016 December | 27 | 8 | 35 |
| 2016 November | 46 | 12 | 58 |
| 2016 October | 65 | 11 | 76 |
| 2016 September | 50 | 22 | 72 |
| 2016 August | 43 | 9 | 52 |
| 2016 July | 56 | 6 | 62 |
| 2016 June | 63 | 12 | 75 |
| 2016 May | 65 | 26 | 91 |
| 2016 April | 46 | 3 | 49 |
| 2016 March | 45 | 0 | 45 |
| 2016 February | 40 | 3 | 43 |
| 2016 January | 61 | 18 | 79 |
| 2015 December | 1 | 1 | 2 |
| 2015 November | 19 | 2 | 21 |
| 2015 October | 50 | 0 | 50 |
| 2015 August | 1 | 0 | 1 |
Show all
